14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 15, 2024 Sell 1 666 Sato Vicki L Common Stock
Apr 01, 2024 Sell 92 500 Krognes Steve E. Common Stock
Mar 29, 2024 Sell 40 000 Watts Ryan J. Common Stock
Mar 15, 2024 Sell 1 666 Sato Vicki L Common Stock
Feb 15, 2024 Sell 1 666 Sato Vicki L Common Stock
Feb 14, 2024 Sell 1 405 Ho Carole Common Stock
Feb 14, 2024 Sell 20 128 Schuth Alexander O. Common Stock
Feb 13, 2024 Sell 2 750 Krognes Steve E. Common Stock
Feb 13, 2024 Sell 9 589 Watts Ryan J. Common Stock
Feb 13, 2024 Sell 2 784 Ho Carole Common Stock
Feb 13, 2024 Sell 2 716 Schuth Alexander O. Common Stock
Feb 08, 2024 Buy 50 000 Schuth Alexander O. Common Stock
Feb 08, 2024 Sell 50 000 Schuth Alexander O. Stock Option (right to buy)
Jan 16, 2024 Sell 1 666 Sato Vicki L Common Stock
Jan 10, 2024 Sell 4 668 Ho Carole Common Stock
Jan 09, 2024 Sell 7 818 Watts Ryan J. Common Stock
Jan 05, 2024 Sell 9 972 Ho Carole Common Stock
Jan 05, 2024 Sell 3 208 Krognes Steve E. Common Stock
Jan 05, 2024 Sell 9 972 Schuth Alexander O. Common Stock
Jan 05, 2024 Sell 17 483 Watts Ryan J. Common Stock
Jan 03, 2024 Buy 53 720 Schuth Alexander O. Common Stock
Jan 03, 2024 Buy 161 160 Schuth Alexander O. Stock Option (right to buy)
Jan 03, 2024 Buy 53 720 Ho Carole Common Stock
Jan 03, 2024 Buy 161 160 Ho Carole Stock Option (right to buy)
Jan 03, 2024 Buy 89 520 Watts Ryan J. Common Stock
Jan 03, 2024 Buy 268 560 Watts Ryan J. Stock Option (right to buy)
Dec 15, 2023 Sell 1 666 Sato Vicki L Common Stock
Nov 15, 2023 Sell 1 666 Sato Vicki L Common Stock
Oct 16, 2023 Sell 1 666 Sato Vicki L Common Stock
Sep 15, 2023 Sell 1 626 Sato Vicki L Common Stock
Sep 15, 2023 Sell 40 Sato Vicki L Common Stock
Aug 23, 2023 Sell 2 522 Schuth Alexander O. Common Stock
Aug 23, 2023 Sell 2 522 Ho Carole Common Stock
Aug 21, 2023 Sell 2 478 Ho Carole Common Stock
Aug 21, 2023 Sell 2 478 Schuth Alexander O. Common Stock
Aug 21, 2023 Sell 2 309 Watts Ryan J. Common Stock
Aug 21, 2023 Sell 1 419 Krognes Steve E. Common Stock
Aug 15, 2023 Sell 1 666 Sato Vicki L Common Stock
Aug 14, 2023 Sell 2 768 Ho Carole Common Stock
Aug 14, 2023 Sell 2 772 Schuth Alexander O. Common Stock
Aug 10, 2023 Buy 2 526 Watts Ryan J. Common Stock
Aug 10, 2023 Sell 2 526 Watts Ryan J. Common Stock
Aug 10, 2023 Sell 2 526 Watts Ryan J. Stock Option (right to buy)
Aug 10, 2023 Sell 2 857 Ho Carole Common Stock
Aug 10, 2023 Sell 2 853 Schuth Alexander O. Common Stock
Jul 18, 2023 Sell 9 702 Schuth Alexander O. Common Stock
Jul 17, 2023 Buy 10 000 Schuth Alexander O. Common Stock
Jul 17, 2023 Sell 10 000 Schuth Alexander O. Common Stock
Jul 17, 2023 Sell 10 000 Schuth Alexander O. Stock Option (right to buy)
Jul 17, 2023 Sell 1 666 Sato Vicki L Common Stock
Jun 28, 2023 Sell 552 Sato Vicki L Common Stock
Jun 28, 2023 Sell 1 114 Sato Vicki L Common Stock
Jun 16, 2023 Buy 50 000 Watts Ryan J. Common Stock
Jun 16, 2023 Sell 50 000 Watts Ryan J. Common Stock
Jun 16, 2023 Sell 50 000 Watts Ryan J. Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Thornberry Nancy Common Stock
Jun 01, 2023 Buy 12 649 Thornberry Nancy Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Krognes Steve E. Common Stock
Jun 01, 2023 Buy 12 649 Krognes Steve E. Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Tessier-lavigne Marc Common Stock
Jun 01, 2023 Buy 12 649 Tessier-lavigne Marc Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Klein Peter S Common Stock
Jun 01, 2023 Buy 12 649 Klein Peter S Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Cook Jennifer E. Common Stock
Jun 01, 2023 Buy 12 649 Cook Jennifer E. Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Schenkein David P Common Stock
Jun 01, 2023 Buy 12 649 Schenkein David P Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Flatley Jay T Common Stock
Jun 01, 2023 Buy 12 649 Flatley Jay T Stock Option (right to buy)
Jun 01, 2023 Buy 12 649 Harris Erik Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Harris Erik Common Stock
Jun 01, 2023 Buy 4 216 Cole Douglas G. Common Stock
Jun 01, 2023 Buy 12 649 Cole Douglas G. Stock Option (right to buy)
Jun 01, 2023 Buy 4 216 Sato Vicki L Common Stock
Jun 01, 2023 Buy 12 649 Sato Vicki L Stock Option (right to buy)
May 15, 2023 Buy 10 000 Schuth Alexander O. Common Stock
May 15, 2023 Sell 9 200 Schuth Alexander O. Common Stock
May 15, 2023 Sell 800 Schuth Alexander O. Common Stock
May 15, 2023 Sell 10 000 Schuth Alexander O. Stock Option (right to buy)
Apr 21, 2023 Buy 24 800 Watts Ryan J. Common Stock
Apr 21, 2023 Sell 24 800 Watts Ryan J. Common Stock
Apr 21, 2023 Sell 24 800 Watts Ryan J. Stock Option (right to buy)
Apr 20, 2023 Buy 200 Watts Ryan J. Common Stock
Apr 20, 2023 Sell 200 Watts Ryan J. Common Stock
Apr 20, 2023 Sell 200 Watts Ryan J. Stock Option (right to buy)
Apr 13, 2023 Buy 4 898 Schuth Alexander O. Common Stock
Apr 13, 2023 Sell 4 898 Schuth Alexander O. Common Stock
Apr 13, 2023 Sell 4 898 Schuth Alexander O. Stock Option (right to buy)
Apr 12, 2023 Buy 5 102 Schuth Alexander O. Common Stock
Apr 12, 2023 Sell 5 102 Schuth Alexander O. Stock Option (right to buy)
Feb 15, 2023 Sell 1 476 Ho Carole Common Stock
Feb 13, 2023 Sell 2 119 Krognes Steve E. Common Stock
Feb 13, 2023 Sell 3 497 Schuth Alexander O. Common Stock
Feb 13, 2023 Buy 25 000 Schuth Alexander O. Common Stock
Feb 13, 2023 Sell 25 000 Schuth Alexander O. Stock Option (right to buy)
Feb 13, 2023 Buy 25 000 Watts Ryan J. Common Stock
Feb 13, 2023 Sell 8 815 Watts Ryan J. Common Stock
Feb 13, 2023 Sell 25 000 Watts Ryan J. Common Stock
Feb 13, 2023 Sell 25 000 Watts Ryan J. Stock Option (right to buy)
Feb 13, 2023 Sell 2 548 Ho Carole Common Stock
INSIDER POWER
32.635
Last 100 transactions
Buy: 1 164 016 | Sell: 631 404 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 32.635.

In total, the insiders bought 1 164 016 and sold 631 404 DNLI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Denali Therapeutics Inc.

Denali Therapeutics. Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for ... DNLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT